Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCEH1 | Q6PIU2 | 4/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29442681 | 1.00 | NCEH1 (0.46) | NCEH1SYKNQO2KDM4ACTSS | |
| SCHEMBL22721522 | 0.91 | SYK (0.44) | NCEH1SYKNQO2KDM4ACTSS | |
| SCHEMBL22721523 | 0.91 | SYK (0.44) | NCEH1SYKNQO2KDM4ACTSS | |
| SCHEMBL29442691 | 0.81 | KDM4A (0.43) | SYKNQO2KDM4ACTSSCTSK | |
| SCHEMBL24650195 | 0.81 | KDM4A (0.43) | SYKNQO2KDM4ACTSSCTSK | |
| SCHEMBL24650176 | 0.80 | NCEH1 (0.54) | NCEH1SMN1; SMN2HPGDNPC1MAPT | |
| Hydrochloric Acid SCHEMBL28705662 | 0.79 | NCEH1 (0.53) | NCEH1SMN1; SMN2HPGDNPC1MAPT | |
| Hydrochloric Acid SCHEMBL28705663 | 0.79 | NCEH1 (0.53) | NCEH1SMN1; SMN2HPGDNPC1MAPT | |
| SCHEMBL22743892 | 0.78 | NCEH1 (0.50) | NCEH1NQO2HPGDDRD2 | |
| SCHEMBL24650612 | 0.75 | POLB (0.36) | SYKNQO2KDM4ASERPINE1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220259223-A1 | BENZOTRIAZOLE DERIVATIVE | UBE INDUSTRIES, LTD. (JP) | 2022-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259223-A1 | BENZOTRIAZOLE DERIVATIVE | KEAP1, NFE2L2, BACH1 | NCEH1 3445/4885SYK 3268/4885NQO2 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.